News Breaks |
|
|
| February 7, 2013 |
| 07:46 EDT |  | CBST, LLY, AMGN, BIIB, PFE, JNJ, SNY, RHHBY | Terrapinn to host a conference
Clinical Outsourcing World Europe Conference is being held in London on February 6-7. |
|
|
News For AMGN;RHHBY;PFE;LLY;SNY;BIIB;CBST;JNJ From The Last 14 Days Check below for free stories on AMGN;RHHBY;PFE;LLY;SNY;BIIB;CBST;JNJ the last two weeks. |
|
|
| May 24, 2013 |
| 11:28 EDT |  | CBST | Options with decreasing implied volatility: WCRX P CBST NTI BBY PXP
|
|
| 10:04 EDT |  | CBST | On The Fly: Analyst Downgrade Summary
 Subscribe for More Information |
|
| 07:54 EDT |  | JNJ | Johnson & Johnson drug business should maintain momentum, says Wells Fargo
After attending J&J's bi-annual pharmaceutical business review, Wells Fargo believes that the revenue generated by four of the company's new drugs could double from 2012 to 2015. The firm thinks the company's pharmaceutical unit has one of the best growth outlooks in the sector, and it keeps an Outperform rating on the stock. |
|
| 07:22 EDT | | CBST | Cubist downgraded at Janney Capital
As previously reported, Janney Capital downgraded Cubist to Neutral from Buy. The firm downgraded shares due to valuation following positive news on the Markman hearings. Price target raised to $55 from $50. |
|
| 07:20 EDT | | BIIB | Celgene, Gilead, and Biogen could go much higher, says Bernstein
Subscribe for More Information |
|
| 06:32 EDT | | CBST | Cubist downgraded to Neutral from Buy at Janney Capital
Subscribe for More Information |
|
| 06:28 EDT | | JNJ | Johnson & Johnson price target raised to $94 from $88 at Leerink
Subscribe for More Information |
|
| May 23, 2013 |
| 15:19 EDT |  | RHHBY | FDA announces approval of Roche diabetes test
Subscribe for More Information |
|
| 11:37 EDT | | CBST | Options with decreasing implied volatility: WCRX CBST NTI BBY TSLA
|
|
| 10:08 EDT |  | JNJ | On The Fly: Analyst Initiation Summary
Subscribe for More Information |
| |
| 08:18 EDT |  | SNY | Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
Subscribe for More Information |
|
| 08:04 EDT | | BIIB | Biogen appoints Spyros Artavanis-Tsakonas as Chief Scientific Officer
Subscribe for More Information |
|
| 07:31 EDT | | JNJ | Janssen expects to have more than 25 brand line extensions by 2017
Subscribe for More Information |
|
| 06:29 EDT | | JNJ | Johnson & Johnson coverage assumed with an Underperform at Credit Suisse
Subscribe for More Information |
|
| May 22, 2013 |
| 16:00 EDT | | JNJ | Options Update; May 22, 2013
Subscribe for More Information |
|
| 12:08 EDT | | CBST | Options with decreasing implied volatility: ARNA SGMO NTAP CBST GDI
|
|
| 10:33 EDT | | RHHBY | Bristol-Myers jumps after Citi ups rating on cancer potential
Subscribe for More Information |
|
| 10:00 EDT |  | RHHBY | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 08:59 EDT | | PFE | On The Fly: Pre-market Movers
Subscribe for More Information |
|
| 08:06 EDT | | PFE | Zoetis comments on Pfizer’s split-off plans for remaining interest
Subscribe for More Information |
| |
|
|
|
|
